Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia.
Although numerous studies of oral manifestations associated with HIV have been reported, only a few refer to the correlation of these lesions with laboratory parameters. In this study we investigated the relationships between the two most common HIV-associated oral lesions, oral candidiasis and hairy leukoplakia, with the stage of the disease, circulating CD4+ cell counts, and the presence of anti-p24 antibodies in serum and stimulated whole saliva in 43 known HIV-1-infected persons. Although oral candidiasis and hairy leukoplakia were exclusively observed in subjects who were classified as Centers for Disease Control and Prevention group IV, only the prevalence of oral candidiasis is strongly associated with circulating CD4+ counts less than 200/mm3 (p < 0.02). The prevalence of oral candidiasis and hairy leukoplakia was significantly related to the absence of anti-p24 antibodies in serum (p < 0.01 and p < 0.01, respectively), but was only statistically significant for hairy leukoplakia in stimulated whole saliva (p < 0.02). The results suggest that oral candidiasis and hairy leukoplakia in correlation with immunologic status as indicated by low circulating CD4+ cell counts and the absence of anti-p24 antibodies in serum and the loss of secretory anti-p24 antibodies in subjects with hairy leukoplakia, may constitute prognostic markers for the progression of HIV-infection to AIDS. Our results also indicate that the absence of anti-p24 antibodies is not only influenced by the low levels of circulating CD4+ cells but probably by the presence of oral candidiasis or hairy leukoplakia as well.
Kolokotronis
A
A
School of Dentistry, Aristotle University of Thessaloniki, Specific Infectious Disease Unit, Greece.
Kioses
V
V
Antoniades
D
D
Mandraveli
K
K
Doutsos
I
I
Papanayotou
P
P
D017088:AIDS-Related Opportunistic Infections / Q000097:blood / Q000276:immunology*; D000293:Adolescent; D000328:Adult; D015415:Biomarkers; D016516:CD4-CD8 Ratio; D002180:Candidiasis, Oral / Q000097:blood / Q000209:etiology / Q000276:immunology*; D016009:Chi-Square Distribution; D005260:Female; D015483:HIV Antibodies / Q000097:blood; D016655:HIV Core Protein p24 / Q000276:immunology; D006801:Humans; D017733:Leukoplakia, Hairy / Q000097:blood / Q000209:etiology / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011379:Prognosis; D012463:Saliva / Q000276:immunology
D015415:Biomarkers; D015483:HIV Antibodies; D016655:HIV Core Protein p24